CervoMed is a public, Boston, MA-based company advancing CNS-focused therapeutics to benefit patients with neurodegenerative diseases. CervoMed was launched in 2014 as EIP Pharma, Inc, by R&D executives from the pharmaceutical and biotech industry. \n\nIn August, 2023 EIP Pharma merged with Diffusion Pharmaceuticals, retaining EIP’s development pipeline, but changing their name to CervoMed (CRVO). \n\nFor more information about the company and updates, please visit www.cervomed.com/ or follow us on Twitter at @Cervo_Med.
CervoMed Address
Boston, MA United States
CervoMed Email
Past Companies
Diffusion PharmaceuticalsVice President Finance
Diffusion PharmaceuticalsSr. Director of Financial Planning & Analysis
Lannett CompanyDirector of Financial Planning and Analysis